Ultrasound-responsive polymer-based drug delivery systems
P Wei, EJ Cornel, J Du - Drug delivery and translational research, 2021 - Springer
Ultrasound-responsive polymeric materials have received a tremendous amount of attention
from scientists for several decades. Compared to other stimuli-responsive materials (such as …
from scientists for several decades. Compared to other stimuli-responsive materials (such as …
Micro‐bio‐chemo‐mechanical‐systems: Micromotors, microfluidics, and nanozymes for biomedical applications
Wireless nano‐/micromotors powered by chemical reactions and/or external fields generate
motive forces, perform tasks, and significantly extend short‐range dynamic responses of …
motive forces, perform tasks, and significantly extend short‐range dynamic responses of …
Therapies from fucoidan: New developments
JH Fitton, DN Stringer, AY Park, SS Karpiniec - Marine Drugs, 2019 - mdpi.com
Since our last review in 2015, the study and use of fucoidan has extended in several
research areas. Clinical use of fucoidan for the treatment of renal disease has become …
research areas. Clinical use of fucoidan for the treatment of renal disease has become …
Nanomaterials for nanotheranostics: tuning their properties according to disease needs
Nanotheranostics is one of the biggest scientific breakthroughs in nanomedicine. Most of the
currently available diagnosis and therapies are invasive, time-consuming, and associated …
currently available diagnosis and therapies are invasive, time-consuming, and associated …
Nanomedicine progress in thrombolytic therapy
Thrombotic occlusions of blood vessels are responsible for life-threatening cardiovascular
disorders such as myocardial infarction, ischemic stroke, and venous thromboembolism …
disorders such as myocardial infarction, ischemic stroke, and venous thromboembolism …
Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy
Thrombosis is a principle cause of various life-threatening cardiovascular diseases.
However, current antithrombotic treatments using drugs only offer limited efficacy due to …
However, current antithrombotic treatments using drugs only offer limited efficacy due to …
Microbubbles for human diagnosis and therapy
L Fournier, T de La Taille, C Chauvierre - Biomaterials, 2023 - Elsevier
Microbubbles (MBs) were observed for the first time in vivo as a curious consequence of
quick saline injection during ultrasound (US) imaging of the aortic root, more than 50 years …
quick saline injection during ultrasound (US) imaging of the aortic root, more than 50 years …
Depriving tumor cells of ways to metastasize: ferroptosis nanotherapy blocks both hematogenous metastasis and lymphatic metastasis
R Guo, M Deng, J Li, X He, P He, H Liu, Y Ye, Z Mo… - Nano Letters, 2023 - ACS Publications
Blood and lymph are two main pathways of tumor metastasis; however, hematogenous
metastasis and lymphatic metastasis are difficult to inhibit simultaneously. Ferroptosis …
metastasis and lymphatic metastasis are difficult to inhibit simultaneously. Ferroptosis …
Advances of nanomedicine in treatment of atherosclerosis and thrombosis
Y Mao, J Ren, L Yang - Environmental research, 2023 - Elsevier
Atherosclerosis (AS) is a chronic inflammatory vascular disease. Myocardial ischemia
originated from AS is the main cause of cardiovascular diseases, one of the major factors …
originated from AS is the main cause of cardiovascular diseases, one of the major factors …
Nano-medicine for thrombosis: a precise diagnosis and treatment strategy
Thrombosis is a global health issue and one of the leading factors of death. However, its
diagnosis has been limited to the late stages, and its therapeutic window is too narrow to …
diagnosis has been limited to the late stages, and its therapeutic window is too narrow to …